US Stock MarketDetailed Quotes

IDYA IDEAYA Biosciences

  • 37.660
  • -0.050-0.13%
Trading May 28 15:47 ET
2.85BMarket Cap-18830P/E (TTM)

About IDEAYA Biosciences Company

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Company Profile

Company NameIDEAYA Biosciences
Listing DateMay 23, 2019
Issue Price10.00
CEOMr. Yujiro S. Hata
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7000 Shoreline Court,Suite 350
CitySouth San Francisco
CountryUnited States of America
Zip Code94080-1945

Company Executives

  • Name
  • Position
  • Salary
  • Yujiro S. Hata
  • Director, President and Chief Executive Officer
  • 6.00M
  • Jason Throne
  • Chief Legal Officer and Corporate Secretary
  • 1.87M
  • Dr. Darrin M. Beaupre, M.D.
  • Chief Medical Officer
  • 1.81M
  • Dr. Michael Anthony White, PhD
  • Chief Scientific Officer
  • 2.76M
  • Andres Ruiz Briseno
  • Principal Financial Officer, Principal Accounting Officer, Senior Vice President, Head of Finance and Investor Relations
  • 1.41M
  • Dr. Terry Rosen, PhD
  • Chairman of the Board
  • 369.52K
  • Dr. Jeffrey Stein, PhD
  • Independent Director
  • 363.02K
  • Dr. Catherine J. Mackey, PhD
  • Independent Director
  • 350.52K
  • Scott W. Morrison
  • Independent Director
  • 364.52K
  • Wendy L. Yarno
  • Independent Director
  • 358.02K
  • Dr. Susan L. Kelley, M.D.
  • Independent Director
  • 349.52K
  • Malcolm Garret Hampton, PhD
  • Independent Director
  • 349.52K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price